1887

Chapter 7 : Human Tuberculosis

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Human Tuberculosis, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817879/9781555812607_Chap07-1.gif /docserver/preview/fulltext/10.1128/9781555817879/9781555812607_Chap07-2.gif

Abstract:

The study of human mycobacterial granuloma is rendered difficult by the limitations of tissue availability and because direct study of protective immune response to is impossible. Bronchoalveolar lavage (BAL) can be used to assess localized lung immune responses during tuberculosis (TB), provides insights into immunologicc ompartmentalization, and may reflect processes in the granulomatous tissue adjacent to the bronchoalveolar spaces. The study of bronchoalveolar cells (BAC) from the bronchoalveolar spaces also allows assessment of alveolar MΦ and lymphocyte functions at the site of disease in the lungs from TB patients. Researchers have recently studied BAC from tuberculin skin test (TST)-positive healthy household contact (HHC) of sputum culture-positive, untreated TB index cases with three-plus-positive sputum smears, i.e., highly infectious cases. Ex vivo studies of cells from the bronchoalveolar spaces have been performed to feasibly obtain cells from the site of infection (reactivation disease) during TB. The most prominent finding of BAL studies in TB patients is a compartmentalized pulmonary immune response. Characterization of alveolar lymphocytes in human pulmonary tuberculosis are provided in this chapter. Understanding of the role of dendritic cells (DC) during mycobacterial infection is emerging. In vitro data indicate that DC are potent antigen-presenting cells as well as activators of T cells. Resolution of granuloma formation after successful TB chemotherapy is evidence for the importance of metabolically active in triggering granulomatous tissue reactions.

Citation: Schwander S, Ellner J. 2003. Human Tuberculosis, p 173-206. In Boros D (ed), Granulomatous Infections and Inflammations. ASM Press, Washington, DC. doi: 10.1128/9781555817879.ch7

Key Concept Ranking

Human immunodeficiency virus 1
0.47252083
Tumor Necrosis Factor alpha
0.44471478
Transforming Growth Factor beta
0.4208757
0.47252083
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Frequencies of IFN-γ-producing cells in PBMC and BAC of tuberculin skin testpositive healthy household contacts of patients with active tuberculosis (HHC) and healthy tuberculin skin test-positive control individuals from the community (CC) by ELISPOT assay. Frequencies of IFN-γ-producing cells in PBMC and BAC from HHC ( = 10) (A) and CC ( = 15) (B) were determined by ELISPOT assay and are expressed as IFN-γ spots per 10 PBMC and BAC. PBMC and BAC were stimulated with PPD and Ag 85 complex from H37Rv culture filtrate (Ag 85co). Control cultures (background) were stimulated with medium alone (Medium). Results are presented as pairs of autologous PBMC and BAC data for each study individual. Visibility of overlapping data points was improved by separating the data points through minor horizontal shifting. •, HHC and CC individuals in whom frequencies of IFN-γ-producing cells in BAC were ≥ 3-fold higher than those in PBMC (for HHC, = 4 for PPD and = 5 for Ag 85co; for CC, = 1 for PPD and = 1 for Ag 85co). Frequencies of IFN-γ-producing BAC in response to Ag 85co were significantly higher in BAC from HHC (A) than in BAC from CC (B) ( = 0.022). Reprinted from reference 116 with permission. © 2000 The American Association of Immunologists, Inc.

Citation: Schwander S, Ellner J. 2003. Human Tuberculosis, p 173-206. In Boros D (ed), Granulomatous Infections and Inflammations. ASM Press, Washington, DC. doi: 10.1128/9781555817879.ch7
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Cytospin preparations of BAC (original magnification, ×160). Wright's stain of BAC from unaffected (A) and affected (B) lung of pulmonary tuberculosis patient shows increase in alveolar lymphocytes in affected lung (arrow); an occasional neutrophil also can be seen. Reprinted from reference 115 with permission of the University of Chicago Press. © 1996 by The University of Chicago. All rights reserved.

Citation: Schwander S, Ellner J. 2003. Human Tuberculosis, p 173-206. In Boros D (ed), Granulomatous Infections and Inflammations. ASM Press, Washington, DC. doi: 10.1128/9781555817879.ch7
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

DNA synthesis by BAC (A) and PBMC (B) to mycobacterial and nonmycobacterial antigens from patients with pulmonary tuberculosis and healthy subjects. BAC and PBMC were stimulated with tetanus toxoid (TT), antigen, 30/32-kDa antigen 85-protein complex from H37Rv culture filtrate (Ag 85), or PPD, and incorporation of [3H]thymidine was determined after 5 days in culture. Responses of unstimulated cells (culture medium) were <1,000 cpm (data not shown). Horizontal lines represent medians. For PPD, = 16 tuberculosis patients and = 23 healthy subjects; for other stimuli, > 5 (both study groups). Reprinted from reference 117 with permission of the University of Chicago Press. © 1998 by the Infectious Diseases Society of America. All rights reserved.

Citation: Schwander S, Ellner J. 2003. Human Tuberculosis, p 173-206. In Boros D (ed), Granulomatous Infections and Inflammations. ASM Press, Washington, DC. doi: 10.1128/9781555817879.ch7
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4
Figure 4

Frequencies of IFN-γ-producing BAC by ELISPOT from patients with pulmonary tuberculosis and healthy subjects, determined in cells stimulated with medium alone (both healthy subjects and tuberculosis patients) or with PPD (healthy subjects [=4], radiographically unaffected lungs from tuberculosis patients [ = 3; two symbols overlap], and radiographically affected lungs from tuberculosis patients [ = 6]). Horizontal lines represent medians. Reprinted from reference 117 with permission of the University of Chicago Press. © 1998 by the Infectious Diseases Society of America. All rights reserved.

Citation: Schwander S, Ellner J. 2003. Human Tuberculosis, p 173-206. In Boros D (ed), Granulomatous Infections and Inflammations. ASM Press, Washington, DC. doi: 10.1128/9781555817879.ch7
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817879.chap7
1. Adams, D. O. 1976. The granulomatous inflammatory response. Am. J. Pathol. 84: 164 191.
2. Agostini, C.,, A. Perin,, and M. D. Semenzato. 1998. Cell apoptosis and granulomatous lung diseases. Curr. Opin. Pulm. Med. 4: 261 266.
3. Ainslie, G. M.,, J. A. Solomon,, and E. D. Bateman. 1992. Lymphocyte and lymphocyte subset numbers in blood and in bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis at presentation and during recovery. Thorax 47: 513 518.
4. Aoki, Y.,, O. Katoh,, Y. Nakanishi,, S. Kuroki,, and H. Yamada. 1994. A comparison study of IFN-γ, ADA, and CA 125 as the diagnosticparameters in tuberculous pleuritis. Respir. Med. 88: 139 143.
5. Aubert-Pivert, E. M.,, F. M. Chedevergne,, G. M. Lopez-Ramirez,, J. H. Colle,, P. L. Scheinmann,, B. M. Gicquel,, and J. M. de Blic. 2000. Cytokine transcripts in pediatric tuberculosis: a study with bronchoalveolar cells. Tuber. Lung Dis. 80: 249 258.
6. Aung, H.,, Z. Toossi,, S. M. McKenna,, P. Gogate,, J. Sierra,, E. Sada,, and E. A. Rich. 2000. Expression of transforming growth factor-β but not tumor necrosis factor-α, interferon- γ, and interleukin-4 in granulomatous lung lesions in tuberculosis. Tuber. Lung Dis. 80: 61 67.
7. Balaji, K. N.,, S. K. Schwander,, E. A. Rich,, and W. H. Boom. 1995. Alveolar macrophages as accessory cells for human gamma delta T cells activated by Mycobacterium tuberculosis. J. Immunol. 154: 5959 5968.
8. Barnes, P. F.,, S. Lu,, J. S. Abrams,, E. Wang,, M. Yamamura,, and R. L. Modlin. 1993. Cytokine production at the site of disease in human tuberculosis. Infect. Immun. 61: 3482 3489.
9. Barnes, P. F.,, S. D. Mistry,, C. L. Cooper,, C. Pirmez,, T. H. Rea,, and R. L. Modlin. 1989. Compartmentalization of a CD4 + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142: 1114 1119.
10. Barnes, P. F.,, S. J. Fong,, P. J. Brennan,, P. E. Twomey,, A. Mazumder,, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-γin tuberculous pleuritis. J. Immunol. 145: 149 154.
11. Bates, J. H. 1980. Transmission and pathogenesis of tuberculosis. Clin. Chest Med. 1: 167 174.
12. Baughman R. P.,, M. N. Dohn,, R. G. Loudon,, and P. T. Frame. 1991. Bronchoscopy with bronchoalveolar lavage in tuberculosis and fungal infections. Chest 99: 92 97.
13. Beckman, E. M.,, S. A. Porcelli,, C. T. Morita,, S. M. Behar,, S. T. Furlong,, and M. B. Brenner. 1994. Recognition of a lipid antigen by CD1-restricted αβ + T cells. Nature 372: 691 694.
14. Bergeron, A.,, M. Bonay,, M. Kambouchner,, D. Lecossier,, M. Riquet,, P. Soler,, A. Hance,, and A. Tazi. 1997. Cytokine patterns in tuberculosis and sarcoid granulomas. Correlations with histopathologicfeatures of the granulomatous response. J. Immunol. 159: 3034 3043.
15. Berman, J. S.,, R. L. Blumenthal,, H. Kornfeld,, J. A. Cook,, W. W. Cruikshank,, M. W. Vermeulen,, D. Chatterjee,, J. T. Belisle,, and M. J. Fenton. 1996. Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitro. J. Immunol. 156: 3828 3835.
16. Bermudez, L. E.,, and J. Goodman. 1996. Mycobacterium tuberculosis invades and replicates within type II alveolar cells. Infect. Immun. 64: 1400 1406.
17. Bermudez, L. E.,, F. J. Sangari,, P. Kolonoski,, M. Petrofsky,, and J. Goodman. 2002. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect. Immun. 70: 140 146.
18. Boom, W. H. 1996. The role of T cell subsets in Mycobacterium tuberculosis infection. Infect. Agents Dis. 5: 73 81.
19. Boussiotis, V. A.,, E. T. Tsai,, E. J. Yunis,, S. Thim,, J. C. Delgado,, C. C. Dascher,, A. Berezovskaya,, D. Rousset,, J.-M. Reynes,, and A. E. Goldfeld. 2000. IL-10 producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105: 1317 1325.
20. Braun, M. M.,, N. Badi,, R. W. Ryder,, E. Baende,, Y. Mukadi,, M. Nsuami,, B. Matela,, J. C. Williame,, M. Kaboto,, and W. Heyward. 1991. A retrospective study of the risk of tuberculosis among women of childbearing age in Zaire. Am. Rev. Respir. Dis. 143: 1055 1064.
21. Canetti, G. 1955. The Tubercle Bacillus in the Pulmonary Lesion of Man. Histobacteriology and Its Bearing on the Therapy of Pulmonary Tuberculosis. Springer Publishing Company, Inc., New York, N.Y.
22. Choi, H.-S.,, P. R. Rai,, H. W. Chu,, C. Cool,, and E. D. Chan. 2002. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 166: 178 186.
23. Daley, C. L.,, P. M. Small,, G. F. Schecter,, G. K. Schoolnik,, R. A. McAdam,, W. R. Jacobs, Jr.,, and P. C. Hopewell. 1992. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N. Engl. J. Med. 326: 231 235.
24. Dhand, R.,, A. De,, N. K. Ganguly,, N. Gupta,, S. Jaswal,, S. K. Malik,, and K. K. Kohli. 1988. Factors influencing the cellular response in bronchoalveolar lavage and peripheral blood of patients with pulmonary tuberculosis. Tubercle 69: 161 173.
25. Dhand, R.,, N. K. Ganguly,, N. Dang,, M. Goyal,, and S. Jaswal. 1990. Effect of chemotherapy on cell counts in peripheral blood and bronchoalveolar lavage of patients with pulmonary tuberculosis. Indian J. Med. Res. 91: 419 424.
26. Di Perri, G.,, A. Cazzadori,, S. Vento,, S. Bonora,, M. Malena,, L. Bontempini,, M. Lanzafame,, B. Allegranzi,, and E. Concia. 1996. Comparative histopathological study of pulmonary tuberculosis in human immunodeficiency virus-infected and non-infected patients. Tuber. Lung Dis. 77: 244 249.
27. Di Perri, G.,, M. Cruciani,, M. C. Danzi,, R. Luzzati,, G. De Checchi,, M. Malena,, S. Pizzighella,, R. Mazzi,, M. Solbiati,, E. Concia,, and D. Bassetti. 1989. Nosocomial epidemic of active tuberculosis among HIV-infected patients. Lancet 30: 1502 1504.
28. Diamond, G.,, D. Legarda,, and L. K. Ryan. 2000. The innate immune response of the respiratory epithelium. Immunol. Rev. 173: 27 38.
29. Diamond, G.,, V. Kaiser,, J. Rhodes,, J. P. Russell,, and C. L. Bevins. 2000. Transcriptional regulation of β-defensin gene expression in tracheal epithelial cells. Infect. Immun. 68: 113 119.
30. Dlugovitzky, D.,, A. Torres-Morales,, L. Rateni,, M. A. Farroni,, C. Largacha,, O. Molteni,, and O. Bottasso. 1997. Circulating profile of Th1 and Th2 cytokines in tuberculosis patients with different degrees of pulmonary involvement. FEMS Immunol. Med. Microbiol. 18: 203 207.
31. Doenhoff, M. J. 1997. A role for granulomatous inflammation in the transmission of infectious disease: schistosomiasis and tuberculosis. Parasitology 115: S113 S125.
32. Doenhoff, M. J. 1998. Granulomatous inflammation and the transmission of infection: schistosomiasis—and TB too? Immunol. Today 19: 462 467.
33. Dye, C.,, S. Scheele,, P. Dolibn,, V. Pathania,, and M. C. Raviglione. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global Surveillance and Monitoring Project. JAMA 282: 677 686.
34. Ellner, J. J. 1978. Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann. Intern. Med. 89: 932 933.
35. Ellner, J. J. 1978. Suppressor adherent cells in human tuberculosis. J. Immunol. 121: 2573 2579.
36. Ellner, J. J. 1997. Regulation of the human immune response during tuberculosis. J. Lab. Clin. Med. 130: 469 475.
37. Ellner, J. J.,, P. F. Barnes,, and R. L. Modlin. 1988. The immunology of tuberculous pleurisy. Semin. Respir. Infect. 3: 335 342.
38. Faith, A.,, D. M. Schellenberg,, A. D. M. Rees,, and D. M. Mitchell. 1992. Antigenic specificity and subset analysis of T cells isolated from the bronchoalveolar lavage and pleural effusion of patients with lung disease. Clin. Exp. Immunol. 87: 272 278.
39. Falcao, R. P.,, and C. Bottura. 1981. A comparative study of lymphocytes in effusions of patients with tuberculosis or malignant disease. Clin. Exp. Immunol. 45: 201 204.
40. Farer, L. S.,, A. M. Lowell,, and M. P. Meador. 1979. Extrapulmonary tuberculosis in the United States. Am. J. Epidemiol. 109: 205 217.
41. Fenhalls, G.,, A. Wong,, J. Bezuidenhout,, P. van Helden,, P. Bardin,, and P. T. Lukey. 2000. In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas. Infect. Immun. 68: 2827 2836.
42. Fenton, M. J.,, M. W. Vermeulen,, S. Kim,, M. Burdick,, R.M. Strieter,, and H. Kornfeld. 1997. Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65: 5149 5156.
43. Ferguson, J. S.,, D. R. Voelker,, J. A. Ufnar,, A. J. Dawson,, and L. S. Schlesinger. 2002. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J. Immunol. 168: 1309 1314.
44. Ferguson, J. S.,, D. R. Voelker,, F. X. McCormack,, and L. S. Schlesinger. 1999. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate- lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J. Immunol. 163: 312 321.
45. Flynn, J. L.,, M. M. Goldstein,, J. Chan,, K. J. Triebold,, K. Pfeffer,, C. J. Lowenstein,, R. Schreiber,, T. W. Mak,, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice. Immunity 2: 561 572.
46. Förtsch, D.,, M. Röllinghoff,, and S. Stenger. 2000. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis. J. Immunol. 165: 978 987.
47. Fujiwara, H.,, and I. Tsuyuguchi. 1986. Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleuritis. Chest 89: 530 532.
48. Fujiwara, H.,, M. E. Kleinhenz,, R. S. Wallis,, and J. J. Ellner. 1986. Increased interleukin- 1 production and monocyte suppressor cell activity associated with human tuberculosis. Am. Rev. Respir. Dis. 133: 73 77.
49. Fujiwara, H.,, Y. Okuda,, T. Fukukawa,, and I. Tsuyuguchi. 1982. In vitro tuberculin reactivity of lymphocytes from patients with tuberculous pleurisy. Infect. Immun. 35: 402 409.
50. Gambon-Deza, F.,, M. Pacheco Carracedo,, T. Cerda Mota,, and J. Montes Santiago. 1995. Lymphocyte populations during tuberculosis infection: Vβ repertoires. Infect. Immun. 63: 1235 1240.
51. Gasser, A.,, and J. Möst. 1999. Generation of multinucleated giant cells in vitro by culture of human monocytes with Mycobacterium bovis BCG in combination with cytokinecontaining supernatants. Infect. Immun. 67: 395 402.
52. Gaynor, C. D.,, F. X. McCormack,, D. R. Voelcker,, S. E. McGowan,, and S. L. Schlesinger. 1995. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155: 5343 5351.
53. Giacomini, E.,, E. Iona,, L. Ferroni,, M. Miettinen,, L. Fattorini,, G. Orefici,, I. Julkunen,, and E. M. Coccia. 2001. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166: 7033 7041.
54. Gilks, C. F.,, R. J. Brindle,, L. S. Otieno,, S. M. Bhatt,, R. S. Newnham,, P. M. Simani,, G. N. Lule,, G. B. A. Okelo,, W. M. Watkins,, P. G. Waiyaki,, J. O. B. Were,, and D. A. Warell. 1990. Extrapulmonary and disseminated tuberculosis in HIV-1-seropositive patients presenting to the acute medical services in Nairobi. AIDS 4: 981 985.
55. Gryzbowski, S.,, G. D. Barnett,, and K. Styblo. 1975. Contacts of cases of active tuberculosis. Bull. Int. Union Tuberc. 50: 90 106.
56. Gursel, G.,, N. Gokcora,, S. Elbeg,, B. Samurkasoglu,, and N. Ekim. 1995. Tumor necrosis factor-α (TNF-α) in pleural fluids. Tuber. Lung Dis. 76: 370 371.
57. Harf, R.,, Y. Frobert,, N. Biot,, C. Lancestre,, C. Ollagnier,, and M. Perin-Fayolle. 1985. Donnees du lavage broncho-alveolaire dans la tuberculose pulmonaire localisee. Rev. Pneumol. Clin. 41: 101 105.
58. Henderson, R. A.,, S. C. Watkins,, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159: 635 643.
59. Hirsch C. S.,, Z. Toossi,, C. Othieno,, J. L. Johnson,, S. K. Schwander,, S. Robertson,, R. S. Wallis,, K. Edmonds,, A. Okwera,, R. Mugerwa,, P. Peters,, and J. J. Ellner. 1999. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J. Infect. Dis. 180: 2069 2073.
60. Hirsch, C. S.,, J. J. Ellner,, D. G. Russell,, and E. A. Rich. 1994. Complement receptormediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152: 743 753.
61. Hirsch, C. S.,, R. Hussain,, Z. Toossi,, G. Dawood,, F. Shahid,, and J. J. Ellner. 1996. Cross-modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon γ production. Proc. Natl. Acad. Sci. USA 93: 3193 3198.
62. Hirsch, C. S.,, Z. Toossi,, G. Vanham,, J. L. Johnson,, P. Peters,, A. Okwera,, R. Mugerwa,, P. Mugyenyi,, and J. J. Ellner. 1999. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J. Infect. Dis. 179: 945 953.
63. Hirsch, C. S.,, Z. Toossi,, J. L. Johnson,, H. Luzze,, L. Ntambi,, P. Peters,, M. McHugh,, A. Okwera,, M. Joloba,, P. Mugyenyi,, R. D. Mugerwa,, P. Terebuh,, and J. J. Ellner. 2001. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J. Infect. Dis. 183: 779 788.
64. Hodsdon, W. S.,, H. Luzze,, T. J. Hurst,, M. A. Quigley,, J. Kyosiimire,, P. B. Namujju,, J. L. Johnson,, P. Kaleebu,, A. Okwera,, and A. M. Elliott. 2001. HIV-1-related pleural tuberculosis: elevated production of IFN-gamma, but failure of immunity to Mycobacterium tuberculosis. AIDS 15: 467 475.
65. Hoheisel, G. B.,, L. Tabak,, H. Teschler,, F. Erkan,, C. Kroegel,, and U. Costabel. 1994. Bronchoalveolar lavage cytology and immunocytology in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149: 460 463.
66. Holland, S. M.,, E. M. Eisenstein,, D. B. Kuhns,, M. L. Turner,, T. A. Fleisher,, W. Strober,, and J. I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. N. Engl. J. Med. 330: 1348 1355.
67. Holt, P. G. 2000. Antigen presentation in the lung. Am. Respir. Crit. Care Med. 162: S151 S156.
68. Houk, V. N.,, J. H. Baker,, K. Sorensen,, and D. C. Kent. 1968. The epidemiology of tuberculosis infection in a closed environment. Arch. Environ. Health 16: 26 35.
69. Houk, V. N. 1980. Spread of tuberculosis via recirculated air in a naval vessel: the Byrd study. Ann. N.Y. Acad. Sci. 353: 10 24.
70. Jouanguy, E.,, F. Altare,, S. Lamhamedi,, P. Revy,, J. F. Emile,, M. Newport,, M. Levin,, S. Blanche,, E. Seboun,, A. Fischer,, and J. L. Casanova. 1996. Interferonγreceptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N. Engl. J. Med. 335: 1956 1961.
71. Kaplan, G.,, and V. H. Freedman. 1996. The role of cytokines in the immune response to tuberculosis. Res. Immunol. 147: 565 572.
72. Keane, J.,, M. K. Malcewicz-Sablinska,, H. G. Remold,, G. L. Chupp,, B. B. Meek,, M. J. Fenton,, and H. Kornfeld. 1997. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect. Immun. 65: 289 304.
73. Keane, J.,, S. Gershon,, R. P. Wise,, E. Mirabile-Levens,, J. Kasznica,, W. D. Schwieterman,, J. N. Siegel,, and M. M. Braun. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent. N. Engl. J. Med. 345: 1098 1104.
74. Kindler, V.,, A.-P. Sappino,, G. E. Grau,, P.-F. Piguet,, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56: 731 740.
75. Kisich, K. O.,, L. Heifets,, M. Higgins,, and G. Diamond. 2001. Antimycobacterial agent based on mRNA encoding human beta-defensin 2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis. Infect. Immun. 69: 2692 2699.
76. Kurashima, K.,, N. Mukaida,, M. Fujimura,, M. Yasui,, Y. Nakazumi,, T. Matsuda,, and K. Matsushima. 1997. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients. Am. J. Respir. Crit. Care Med. 155: 1474 1477.
77. Law, K.,, J. Jagirdir,, M. D. Weiden,, M. Bodkin,, and W. N. Rom. 1996. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am. J. Respir. Crit. Care Med. 153: 1377 1384.
78. Law, K.,, M. Weiden,, T. Harkin,, K. Tchou-Wong,, C. Chi,, and W. N. Rom. 1996. Increased release of interleukin-1β, interleukin-6, and tumor necrosis factor-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153: 799 804.
79. Lawn, S. D.,, S. T. Butera,, and T. M. Shinnick. 2002. Tuberculosis unleashed: the impact of human immunodeficiency virus infection on the host granulomatous response to Mycobacterium tuberculosis. Microb. Infect. 4: 635 646.
80. Light, R. W., 1995. Tuberculous pleural effusions, p. 154 166. In D. C. Retford (ed.), Pleural Diseases, 3rd ed. Williams & Wilkins, Baltimore, Md.
81. Lin, Y.,, M. Zhang,, and P. F. Barnes. 1998. Chemokine production by a human alveolar epithelial cell line in response to Mycobacterium tuberculosis. Infect. Immun. 66: 1121 1126.
82. Lorgat, F.,, M. M. Keraan,, and S. R. Ress. 1992. Compartmentalization of the cellular immune response to the recombinant 65 kDa protein of Mycobacterium bovis BCG in patients with tuberculous pleuritis. Reg. Immunol. 4: 12 17.
83. Loudon, R. G.,, and R. M. Roberts. 1967. Droplet expulsion from the respiratory tract. Am. Rev. Respir. Dis. 95: 435 442.
84. Lucas, S. B.,, A. Hounnou,, C. Peacock,, A. Beaumel,, G. Djomand,, J. M. N'Gbichi,, K. Yeboue,, M. Honde,, M. Diomande,, C. Giordano,, R. Doorly,, K. Brattegaard,, L. Kestens,, R. Smithwick,, A. Kadio,, N. Ezani,, A. Yapi,, and K. M. De Cock. 1993. The mortality and pathology of HIV infection in a West African city. AIDS 7: 1569 1579.
85. Lucas, S. B.,, and A. M. Nelson,. 1994. Pathogenesis of tuberculosis in human immunodeficiency virus-infected people, p. 503 513. In B. R. Bloom (ed.), Tuberculosis: Pathogenesis, Protection, and Control. ASM Press, Washington, D.C.
86. Lucivero, G.,, G. Pierucci,, and L. Bonomo. 1988. Lymphocyte subsets in peripheral blood and pleural fluid. Eur. Resp. J. 1: 337 340.
87. Maeda, J.,, N. Ueki,, T. Ohkawa,, N. Iwahashi,, T. Nakano,, T. Hada,, and K. Higashino. 1993. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin. Exp. Immunol. 92: 32 38.
88. Manca, C.,, L. Tsenova,, A. Bergtold,, S. Freeman,, M. Tovey,, J. M. Musser,, C. E. Barry III,, V. H. Freedman,, and G. Kaplan. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. USA 98: 5752 5757.
89. Mehta, P. K.,, C. H. King,, E. H. White,, J. J. Murtagh, Jr.,, and F. D. Quinn. 1996. Comparison of in vitro models for the study of Mycobacterium tuberculosis invasion and intracellular replication. Infect. Immun. 64: 2673 2679.
90. Nau, G. J.,, J. F. L. Richmond,, A. Schlesinger,, E. G. Jennings,, E. S. Lander,, and R. A. Young. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99: 1503 1508.
91. Nau, G. J.,, P. Guilfoile,, G. L. Chupp,, J. S. Berman,, J. S. Kim,, H. Kornfeld,, and R. A. Young. 1997. A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc. Natl. Acad. Sci. USA 94: 6414 6419.
92. Newport, M. J.,, C. M. Huxley,, S. Huston,, C. M. Hawrylowicz,, B. A. Oostra,, R. Williamson,, and M. A. Levin. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941 1949.
93. Ni, K.,, and H. C. O'Neill. 1997. The role of dendritic cells in T cell activation. Immunol. Cell. Biol. 75: 223 230.
94. Nicholson, S.,, M. G. Bonecini-Almeida,, J. R. Lapa e Silva,, C. Nathan,, Q-W. Xie,, R. Mumford,, J. R. Weidner,, J. Calaycay,, J. Geng,, N. Boechat,, C. Linhares,, W. Rom,, and J. L. Ho. 1996. Inducible nitric oxide synthase in pulmonary macrophages from patients with tuberculosis. J. Exp. Med. 183: 2293 2302.
95. Nowakowski, M.,, S. P. Chan,, P. Steiner,, S. Chice,, and H. G. Durkin. 1992. Different distributions of lung and blood lymphocyte subsets in pediatric AIDS or tuberculosis. Ann. Clin. Lab. Sci. 22: 377 384.
96. Nozaki, Y.,, Y. Hasegawa,, S. Ichiyama,, I. Nakashima,, and K. Shimokata. 1997. Mechanism of nitricoxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages. Infect. Immun. 65: 3644 3647.
97. O'Brien, L.,, and P. W. Andrew. 1996. In vitro interaction of Mycobacterium tuberculosis and macrophages: activation of anti-mycobacterial activity of macrophages and mechanisms of anti-mycobacterial activity. Curr. Top. Microbiol. Immunol. 215: 97 130.
98. Oddo, M.,, T. Renno,, A. Attinger,, T. Bakker,, H. R. MacDonald,, and P. R. A. Meylan. 1998. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 160: 5448 5454.
99. Ogawa, K.,, H. Koga,, Y. Hirakata,, K. Tomono,, T. Tashiro,, and S. Kohno. 1997. Differential diagnosis of tuberculous pleurisy by measurement of cytokine concentrations in pleural effusion. Tuber. Lung Dis. 78: 29 34.
100. Ozaki, T.,, S. Nakahira,, K. Tani,, F. Ogushi,, S. Yasuoka,, and T. Ogura. 1992. Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis. Chest 102: 54 59.
101. Pettersson, T.,, M. Klockars,, P. E. Hellstroem,, H. Riska,, and A. Wangel. 1978. T and B lymphocytes in pleural effusions. Chest 73: 49 51.
102. Pitchenik, A. E.,, and H. A. Rubinson. 1985. The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS. Am. Rev. Respir. Dis. 131: 393 396.
103. Ratcliffe, H. L. 1952. Tuberculosis induced by droplet nuclei infection. Am. J. Hyg. 55: 36 48.
104. Remoli, M. E.,, E. Giacomini,, G. Lutfalla,, E. Dondi,, G. Orefici,, A. Battistini,, G. Uze,, S. Pellegrini,, and E. M. Coccia. 2002. Selective expression of type I IFN genes in human dendritic cells infected with Mycobacterium tuberculosis. J. Immunol. 169: 366 374.
105. Ribeiro-Rodrigues R.,, T. Resende Co,, J. L. Johnson,, F. Ribeiro,, M. Palaci,, R. T. Sa,, E. L. Maciel,, F. E. Pereira Lima,, V. Dettoni,, Z. Toossi,, W. H. Boom,, R. Dietze,, J. J. Ellner,, and C. S. Hirsch. 2002. Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance. Clin. Diagn. Lab. Immunol. 9: 818 823.
106. Rich, E. A.,, J. R. Panuska,, R. S. Wallis,, C. B. Wolf,, M. L. Leonard,, and J. J. Ellner. 1989. Dyscoordinate expression of tumor necrosis factor-alpha by human blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 139: 1010 1016.
107. Rieder, H. L.,, G. M. Cauthen,, G. W. Comstock,, and D. E. Snider, Jr. 1989. Epidemiology of tuberculosis in the United States. Epidemiol. Rev. 11: 79 98.
108. Riley, R. L.,, and C. C. Mills. 1962. Infectiousness of air from a tuberculosis ward. Am. Rev. Respir. Dis. 85: 511 525.
109. Robinson, D. S.,, S. Ying,, I. K. Taylor,, A. Wangoo,, D. M. Mitchell,, A. B. Kay,, Q. Hamid,, and R. J. Shaw. 1994. Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 149: 989 993.
110. Rouillon, A.,, S. Pedrizet,, and R. Parrot. 1976. Transmission of tubercle bacilli: the effects of chemotherapy. Tubercle 57: 275 299.
111. Sadek, M.,, E. Sada,, Z. Toossi,, S. K. Schwander,, and E. A. Rich. 1998. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis. Am. J. Respir. Cell Mol. Biol. 19: 513 521.
112. Samten, B.,, P. Ghosh,, A-K. Yi,, S. E. Weis,, D. L. Lakey,, R. Gonsky,, U. Pendurthi,, B. Wizel,, Y. Zhang,, M. Zhang,, J. Gong,, M. Fernandez,, H. Safi,, R. Vankayalapati,, H. A. Young,, and P. F. Barnes. 2002. Reduced expression of nuclear cyclic adenosine 5'- monophosphate response element-binding proteins and IFN-γ promoter function in disease due to an intracellular pathogen. J. Immunol. 168: 3520 3526.
113. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150: 2920 2930.
114. Schlesinger, L. S.,, C. G. Bellinger-Kawahara,, N. R. Payne,, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component 3. J. Immunol. 144: 2771 2780.
115. Schwander, S. K.,, E. Sada,, M. Torres,, D. Escobedo,, J. G. Sierra,, and E. A. Rich. 1996. T Lymphocytic and immature macrophage alveolitis in active pulmonary tuberculosis. J. Infect. Dis. 173: 1267 1272.
116. Schwander, S. K.,, M. Torres,, C. Carranza,, D. Escobedo,, M. Tary-Lehmann,, P. Andersen,, Z. Toossi,, J. J. Ellner,, E. A. Rich,, and E. Sada. 2000. Pulmonary mononuclear cell responses to antigens of Mycobacterium tuberculosis in healthy household contacts of patients with active tuberculosis and healthy controls from the community. J. Immunol. 165: 1479 1485.
117. Schwander, S. K.,, M. Torres,, E. Sada,, C. Carranza,, E. Ramos,, M. Tary-Lehmann,, R. S. Wallis,, J. Sierra,, and E. A. Rich. 1998. Enhanced responses to Mycobacterium tuberculosis antigens by human alveolar lymphocytes during active pulmonary tuberculosis. J. Infect. Dis. 178: 1434 1445.
118. Selwyn, P. A.,, D. Hartel,, V. A. Lewis,, E. E. Schoenbaum,, S. H. Vermund,, R. S. Klein,, A. T. Walker,, and G. H. Friedland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320: 545 550.
119. Sertl, K.,, T. Takemura,, E. Tschachler,, V. J. Ferrans,, M. A. Kaliner,, and E. M. Shevach. 1986. Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma, and visceral pleura. J. Exp. Med. 163: 436 451.
120. Shaw, J. B.,, and N. Wynn-Williams. 1954. Infectivity of pulmonary tuberculosis in relation to sputum status. Am. Rev. Tuberc. 69: 723 732.
121. Shimokata, K.,, H. Kawachi,, H. Kishimoto,, F. Maeda,, and Y. Ito. 1982. Local cellular immunity in tuberculous pleurisy. Am. Rev. Respir. Dis. 126: 822 824.
122. Shimokata, K.,, H. Saka,, T. Murate,, Y. Hasegawa,, and T. Hasegawa. 1991. Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. Chest 99: 1103 1107.
123. Shiratsuchi, H.,, and I. Tsuyuguchi. 1984. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin. Clin. Exp. Immunol. 57: 271 278.
124. Sieling, P. A.,, D. Chatterjee,, S. A. Porcelli,, T. I. Prigozy,, R. J. Mazzaccaro,, T. Soriano,, B. R. Bloom,, M. B. Brenner,, M. Kronenberg,, P. J. Brennan,, and R. L. Modlin. 1995. CD-1 restricted T cell recognition of microbial lipoglycan antigens. Science 269: 227 230.
125. Small, P. M.,, G. F. Schecter,, P. C. Goodman,, M. A. Sande,, R. E. Chaisson,, and P. C. Hopewell. 1997. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 324: 289 294.
126. Smith, S.,, D. Liggitt,, E. Jeromsky,, X. Tan,, S. J. Skerrett,, and C. B. Wilson. 2002. Local role for tumor necrosis factor alpha in the pulmonary inflammatory response to Mycobacterium tuberculosis infection. Infect. Immun. 70: 2082 2089.
127. Taha, R. A.,, T. C. Kotsimbos,, Y. L. Song,, D. Menzies,, and Q. Hamid. 1997. IFNgamma and IL-12 are increased in active compared with inactive tuberculosis. Am. J. Respir. Crit. Care Med. 155: 1135 1139.
128. Tan, J. S.,, D. H. Canaday,, W. H. Boom,, K. N. Balaji,, S. K. Schwander,, and E. A. Rich. 1997. Human alveolar T lymphocyte responses to Mycobacterium tuberculosis antigens: role for CD4 + and CD8 + cytotoxic T cells and relative resistance of alveolar macrophages to lysis. J. Immunol. 159: 290 297.
129. Ting, L. M.,, A. C. Kim,, A. Cattamanchi,, and J. D. Ernst. 1999. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT-1. J. Immunol. 163: 3898 3906.
130. Toossi, Z.,, B. D. Hamilton,, M. H. Phillips,, L. E. Averill,, J. J. Ellner,, and A. Salvekar. 1997. Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J. Immunol. 159: 4109 4116.
131. Toossi, Z.,, M. E. Kleinhenz,, and J. J. Ellner. 1986. Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis. J. Exp. Med. 163: 1162 1172.
132. Toossi, Z.,, T.-G. Young,, L. E. Averill,, B. D. Hamilton,, H. Shiratsuchi,, and J. J. Ellner. 1995. Induction of transforming growth factor-beta 1 by purified protein derivative (PPD) of Mycobacterium tuberculosis. Infect. Immun. 63: 224 228.
133. Valdes, L.,, D. Alvarez,, E. San Jose,, P. Penela,, J. M. Valle,, J. M. Garcia-Pazos,, J. Suarez,, and A. Pose. 1998. Tuberculous pleurisy. A study of 254 patients. Arch. Intern. Med. 158: 2017 2021.
134. Vanham, G.,, K. Edmonds,, L. Qing,, D. Hom,, Z. Toossi,, B. Jones,, C. L. Daley,, R. Huebner,, L. Kestens,, P. Gigase,, and J. J. Ellner. 1996. Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin. Exp. Immunol. 103: 30 34.
135. Wallis, R. S.,, M. Amir-Tahmasseb,, and J. J. Ellner. 1990. Induction of interleukin-1 and tumor necrosis factor by mycobacterial proteins: the monocyte Western blot. Proc. Natl. Acad. Sci. USA 87: 3348 3352.
136. Wang, C. H.,, C. Y. Liu,, H. C. Lin,, C. T. Yu,, K. F. Chung,, and H. P. Kuo. 1998. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 11: 809 815.
137. Wells, W. F.,, H. L. Ratcliffe,, and C. Crumb. 1948. On the mechanics of droplet nuclei infection. II. Quantitative experimental air-borne tuberculosis in rabbits. Am. J. Hyg. 47: 11 28.
138. World Health Organization/International Union against Tuberculosis and Lung Disease. Anti-Tuberculosis Drug Resistance in the World. Report No. 2. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1997-2000. WHO/CDS/ TB/2000.278. World Health Organization, Geneva, Switzerland.
139. Yokoyama, A.,, M. Maryuyama,, M. Ito,, N. Kohno,, K. Hiwada,, and S. Yano. 1992. Interleukin 6 activity in pleural effusion. Its diagnosticvalue and thrombopoieticac tivity. Chest 102: 1055 1059.
140. Zhang, M.,, M. K. Gately,, E. Wang,, J. Gong,, S. F. Wolf,, S. Lu,, R. L. Modlin,, and P. F. Barnes. 1994. Interleukin 12 at the site of disease in tuberculosis. J. Clin. Investig. 93: 1733 1739.
141. Zhang, M.,, Y. Lin,, D. V. Iyer,, J. Gong,, J. S. Abrams,, and P. F. Barnes. 1995. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect. Immun. 63: 3231 3234.
142. Zhang, Y.,, M. Broser,, H. Cophen,, M. Bodkin,, K. Law,, J. Reibman,, and W. M. Rom. 1995

Tables

Generic image for table
Table 1

Characterization of alveolar lymphocytes in human pulmonary tuberculosis

Citation: Schwander S, Ellner J. 2003. Human Tuberculosis, p 173-206. In Boros D (ed), Granulomatous Infections and Inflammations. ASM Press, Washington, DC. doi: 10.1128/9781555817879.ch7

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error